Sort
51,593 grants matching “hepatitis”
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$623,171Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Development of high-throughput cardiotoxicity and hepatotoxicity assays with magnetic 3D bioprinting
$623,123Hubert Tseng · Nano3d Biosciences, Inc. · R44 · FY2017 · ES
INSULIN RECEPTORS AND INSULIN ACTION
$623,107Vanderbilt University · R37 · FY2000 · DK
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$622,961Gregory M Lanza · Washington University · R01 · FY2018 · CA
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$622,961Gregory M Lanza · Washington University · R01 · FY2021 · CA
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$622,961Gregory M Lanza · Washington University · R01 · FY2020 · CA
CCR FACS Core Laboratory
$622,887Barbara Taylor · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
In Vivo And In Vitro Studies Of Hepatitis E Virus
$622,855Suzanne Emerson · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$622,831Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DK
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
$622,812Shannon Gwin Mitchell · Friends Research Institute, Inc. · R01 · FY2015 · DA
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
$622,753Joshua T Herbeck · University Of Washington · R01 · FY2018 · DA
Adjuvanted Epitope Vaccine to Target HIV Reservoirs
$622,638University Of Pittsburgh At Pittsburgh · R01 · FY2004 · AI
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery
$622,615Ramasamy Paulmurugan · Stanford University · R01 · FY2020 · CA
Genetic Modifiers of Liver Disease Severity in Alagille Syndrome
$622,582Nancy Bettina Spinner · Children'S Hosp Of Philadelphia · R01 · FY2009 · DK
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.
$622,519Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2023 · ES
Structure and Replication of Hepatitis Delta Virus
$622,504Institute For Cancer Research · R01 · FY2005 · AI
Police Training to Reduce Occupational Needlesticks and HIV among Substance Users
$622,357Steffanie A Strathdee · University Of California, San Diego · R01 · FY2019 · DA
UNDERSTANDING HEPATIC PROTEOSTASIS IN SYSTEMIC AMYLOID DISEASES
$622,341Rockland L Wiseman · Scripps Research Institute, The · R01 · FY2021 · DK
Next Generation of Recombinant AAV Serotype For Gene Therapy
$622,223Roland W. Herzog · University Of Florida · R01 · FY2016 · HL
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis
$622,146Naji N Abumrad · Vanderbilt University · R01 · FY2011 · DK
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$622,068Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2022 · CA
Rhesus HHV-8 homologue in AIDS-related malignancies
$622,052Scott W Wong · Oregon Health & Science University · R01 · FY2010 · CA
Clinical Research Resources and Facilities
$622,019Judith E Feinberg · West Virginia University · U54 · FY2020 · GM
Insulin regulation of hepatic transport
$621,908Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2023 · DK
Understanding human antibody responses to chronic viral hepatitis C
$621,806Mansun Law · Scripps Research Institute, The · R01 · FY2022 · AI